Clinical trial · Interventional
Lymph Node Mapping Via Flourescent Dye in Colon Cancer
Lymph Node Mapping Via the Flourescent Dye ICG in Colon Cancer Through Preoperative Application
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The aim of the study is to evaluate whether lymph nodes draining the region of the carcinoma are located only inside the lines of standard resection or in some percentages are located outside as well. The visualized nodes draining the region of the carcinoma will be correlated to location, fluorescent yes/no and nodal positive/negative. The draining lymph nodes will be visualized using the fluorescent dye indocyanine green. The aim of the study is to evaluate whether lymph nodes draining the region of the carcinoma are located only inside the lines of standard resection or in some percentages are located outside as well. The visualized nodes draining the region of the carcinoma will be correlated to location, fluorescent yes/no and nodal positive/negative. The draining lymph nodes will be visualized using the fluorescent dye indocyanine green.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Colon Carcinoma | Colon Carcinoma | ONTOLOGY_EXACT | 0.98 |
| Lymph Node Metastases | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| ICG-marking endoscopically | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- ICG-marked Colon Carcinoma
- description
- The participants will receive an endoscopic marking via ICG preoperatively
- interventionNames
- Procedure: ICG-marking endoscopically
Primary outcomes (4)
- measure
- Intraoperative ICG-positive lymph nodes in vivo after endoscopic marking of the tumour
- timeFrame
- intraoperative assessment
- description
- Counting ICG-positive sites intraoperatively
- measure
- Video-analysis of ICG-positive lymph nodes in vivo after endoscopic marking of the tumour
- timeFrame
- video-analysis within one week after surgery
- description
- Counting ICG-positive sites video-analysis
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 100 Years
Show eligibility criteria text
Inclusion Criteria: * histologically diagnosed carcinoma of the ascending, transverse, descending or sigmoid colon. Exclusion Criteria: * not wanting to participate * other carcinoma then adenocarcinoma * endoscopic marking not possible
References
Publications (0)
Data not yet available